New method may reduce cancer therapies' toxicity

This site uses cookes. By using this site you are consenting to their use according to our Cookie policy.

i agree

All Events Lab People Project Training News Equipment

Highlights of {{searchTotal}} search results

View all search results

CARE

CARE : Boosting Clinical Research for the Benefit of Society, is a Teaming for Excellence project, in collaboration with the Vall d'Hebron Institut de Recerca (VHIR), in Barcelona. Pioneering in Portugal, with a core missiondriven, human-centered and data-driven research and innovation model, based on the involvement of all stakeholders - citizens, patients, health
professionals, researchers, business people, industry, health authorities and government.

Translational Research Lines
Mission Lab
Biobank
About

About : Know more about the iMM, a Biomedical research institute of excellence, conducting basic and clinical research with the mission of improving human life.

iMM
People
Numbers
Organization Chart
Research

Research : Our research is driven by curiosity, passion and desire of our researchers to move forward the state-of-the-art, supported by technical and administrative facilities that combine excellent instrumentation and dedicated staff.Check the upcoming events at iMM.

Laboratories
Spin-Offs
Support Infrastructure
Events
Training

Training : iMM offers a set of integrated programmes to researchers at different stages of their careers, designed to provide the best training and contributing for successful careers in science.

Masters
PhD
Postdoctoral
Courses
Society

Society : Taking the knowledge produced at iMM to the benefit and well-being of all and contribute to the establishment of an informed society.

Fundraising
International Projects
Outreach
Innovation
Contacts

en pt

Gonçalo Bernardes' team, iMM Lisboa, has developed a technique that may reduce the toxicity to cancer therapies. By binding a monoclonal antibody to anti-cancer medication, therapies can be more efficiently targeted towards the tumors.

New method may reduce cancer therapies’ toxicity